<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03244748</url>
  </required_header>
  <id_info>
    <org_study_id>ozcan01</org_study_id>
    <nct_id>NCT03244748</nct_id>
  </id_info>
  <brief_title>Amiodarone Usage After Ischemic Ventricular Tachycardia Ablation</brief_title>
  <official_title>Effect of Amiodarone After Ischemic Ventricular Tachycardia Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yuksek Ihtisas Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yuksek Ihtisas Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventricular Tachycardia ablation in ischemic cardiomyopathy patients is required procedure in
      cases when anti-arrhythmic drugs failed. The concern is if adjunctive continuation amiodarone
      after ablation is needed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ischemic cardiomyopathy patients have implantable cardioverter defibrillators (ICD) to
      prevent arrhythmic deaths. Ventricular tachycardia (VT) events with frequent ICD
      interventions in ischemic cardiomyopathy patients is encountered frequently. Frequents ICD
      interventions is associated with worse outcomes. Anti-arrhythmic drugs ,mostly amiodarone,
      are given prevent ventricular arrhythmias and ICD interventions that may not be curative.
      Ablation of ventricular tachycardia is the suggested treatment when anti-drugs are without
      effect. After ablation of ventricular arrhythmia the continuation of amiodarone is not well
      elucidated.

      In this study we aimed to enroll ischemic cardiomyopathy patients having frequent ICD
      interventions despite medical treatment. VT ablation is performed and patients divided into
      two groups; group one continues having amiodarone after ablation, group two does not have
      amiodarone after ablation. Both groups will be compared in terms of recurrence and death.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Anticipated">March 1, 2018</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Major adverse cardiovascular events</measure>
    <time_frame>six months</time_frame>
    <description>Death, ICD intervetion</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ischemic Cardiomyopathy</condition>
  <condition>Ventricular Tachycardia</condition>
  <condition>ICD Shock</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>Patients underwent ablation and continued having amiodarone after the procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>Patients underwent ablation and not having amiodarone after the procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ventricular tachycardia ablation</intervention_name>
    <description>Electrophysiologic procedure aims to ablate and terminate arrhythmia percutaneously</description>
    <arm_group_label>Group 1</arm_group_label>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        We enroll ischemic heart failure patients who had frequent ventricular arrhythymias causing
        multiple shocks.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Ischemic cardiomyopathy patients applied with frequent ICD interventionor electrical storms
        and having ejection fraction below 50%. Frequent ICD defined as more than 1 ICD
        intervention within month. Electrical storm defined as more than 2 ICD intervention within
        one day.

        Exclusion Criteria:

        Patients with cardiomyopathies other than ischemic etiology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Firat Ozcan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MD</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Firat Ozcan, Ass. Prof, MD</last_name>
    <phone>+905327854000</phone>
    <email>drfozcan@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Turkiye Yuksek Ihtisas Training and Research Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06590</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Firat Ozcan, Ass. Prof, MD</last_name>
      <phone>5327854000</phone>
      <email>drfozcan@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 5, 2017</study_first_submitted>
  <study_first_submitted_qc>August 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2017</study_first_posted>
  <last_update_submitted>August 5, 2017</last_update_submitted>
  <last_update_submitted_qc>August 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yuksek Ihtisas Hospital</investigator_affiliation>
    <investigator_full_name>Fırat Özcan</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Tachycardia</mesh_term>
    <mesh_term>Tachycardia, Ventricular</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amiodarone</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

